Page last updated: 2024-11-03

probenecid and Angina Pectoris

probenecid has been researched along with Angina Pectoris in 1 studies

Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.

Angina Pectoris: The symptom of paroxysmal pain consequent to MYOCARDIAL ISCHEMIA usually of distinctive character, location and radiation. It is thought to be provoked by a transient stressful situation during which the oxygen requirements of the MYOCARDIUM exceed that supplied by the CORONARY CIRCULATION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
KNAPP, HA1

Other Studies

1 other study available for probenecid and Angina Pectoris

ArticleYear
Uricosuric treatment in angina pectoris.
    Lancet (London, England), 1963, Jan-05, Volume: 1, Issue:7271

    Topics: Angina Pectoris; Colchicine; Gout; Humans; Probenecid

1963